Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases

Vascular Pharmacology

Volumn 100, Issue , 2018, Pages 1-19

  Incalza, Maria Angela ^a   D'Oria, Rossella ^a   Natalicchio, Annalisa ^a   Perrini, Sebastio ^a   Laviola, Luigi ^a   Giorgino, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Endothelium; ER stress; Hyperglycemia; Inflammation; Lipotoxicity

Indexed keywords

ANTIOXIDANT; CATALASE; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MICRORNA; PEROXIDASE; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; THIOREDOXIN; XANTHINE OXIDASE; AUTACOID; NITRIC OXIDE;

AGING; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC DISORDER; MITOCHONDRION; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR DISEASES; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; METABOLIC DISEASES; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 85020316170     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2017.05.005     Document Type: Review

References (289)

1. Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20:7 (2014), 1126–1167, 10.1089/ars.2012.5149.
2. Nishikawa, T., Edelstein, D., Liang Du, X., Yamagishi, S., Matsumura, T., KanedaY et al. normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:6779 (2000), 787–790, 10.1038/35008121.
3. Thomas, S.R., Witting, P.K., Drummond, G.R., Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 10 (2008), 1713–1765, 10.1089/ars.2008.2027.
4. Thannickal, V.J., Fanburg, B.L., Reactive oxygen species in cell signaling. Am. J. Phys. Lung Cell. Mol. Phys. 279:6 (2000), L1005–L1028 (PMID: 11076791, PubMed - indexed for MEDLINE).
5. Dröge, W., Free radicals in the physiological control of cell function. Physiol. Rev. 82:1 (2002), 47–95, 10.1152/physrev.00018.2001.
6. Sena, L.A., Chandel, N.S., Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48 (2012), 158–167, 10.1016/j.molcel.2012.09.025.
7. Bretòn-Romero, R., Lamas, S., Hydrogen peroxide signaling in vascular endothelial cells. Redox Biol. 2 (2014), 529–534, 10.1016/j.redox.2014.02.005.
8. Uttara, B., Singh, A.V., Zamboni, P., Mahajan, R.T., Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7:1 (2009), 65–74, 10.2174/157015909787602823.
9. Sosa, V., Moliné T., Somoza, R., Paciucci, R., Kondoh, H., LLeonart, M.E., Oxidative stress and cancer: an overview. Ageing Res. Rev. 12:1 (2013), 376–390, 10.1016/j.arr.2012.10.004.
10. Massy, Z.A., NguyenKhoa, T., Oxidative stress and chronic renal failure: markers and management. J. Nephrol. 15:4 (2002), 336–341 (PMID: 12243361, PubMed - indexed for MEDLINE).
11. Park, H.S., Chun, J.N., Jung, H.Y., Choi, C., Bae, Y.S., Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc. Res. 72 (2006), 447–455, 10.1016/j.cardiores.2006.09.012.
12. Liao, J.K., Linking endothelial dysfunction with endothelial cell activation. J. Clin. Invest. 123:2 (2013 Feb), 540–541, 10.1172/JCI66843.
13. Bulua, A.C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.Y. et al., Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med. 208:3 (2011), 519–533, 10.1084/jem.20102049.
14. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C. et al., Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12:3 (2011), 222–230, 10.1038/ni.1980.
15. Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469:7329 (2011 Jan 13), 221–225, 10.1038/nature09663.
16. Landmesser, U., Dikalov, S., Price, S.R., McCann, L., Fukai, T., Holland, S.M., Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cellnitric oxide synthase in hypertension. J. Clin. Invest. 111:8 (2003), 1201–1209, 10.1172/JCI14172.
17. Potenza, M.A., Gagliardi, S., Nacci, C., Carratu, M.R., Montagnani, M., Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr. Med. Chem. 16:1 (2009), 94–112, 10.2174/092986709787002853.
18. Wolin, M.S., Gupte, S.A., Neo, B.H., Gao, Q., Ahmad, M., Oxidant-redox regulation of pulmonary vascular responses to hypoxia and nitric oxide-cGMP signaling. Cardiol. Rev. 18:2 (2010), 89–93, 10.1097/CRD.0b013e3181c9f088.
19. Liaudet, L., Vassalli, G., Pacher, P., Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front. Biosci. (Landmark Ed.) 14 (2009), 4809–4814 (PMID:19273391, PubMed-indexed for MEDLINE).
20. Radi, R., Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U. S. A. 101:12 (2004), 4003–4008, 10.1073/pnas.0307446101.
21. Mathews, M.T., Berk, B.C., PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler. Thromb. Vasc. Biol. 28:4 (2008), 711–717, 10.1161/ATVBAHA.107.156406.
22. Dharmashankar, K., Widlansky, M.E., Vascular endothelial function and hypertension: insights and directions. Curr. Hypertens. Rep. 12:6 (2010), 448–455, 10.1007/s11906-010-0150-2.
23. Toda, N., Nakanishi-Toda, M., How mental stress affects endothelial function. Pflugers Arch. 462:6 (2011), 779–794, 10.1007/s00424-011-1022-6.
24. Herrera, M.D., Mingorance, C., Rodríguez-Rodríguez, R., Alvarez de Sotomayor, M., Endothelial dysfunction and aging: an update. Ageing Res. Rev. 9:2 (2010), 142–152, 10.1016/j.arr.2009.07.002.
25. Soultati, A., Mountzios, G., Avgerinou, C., Papaxoinis, G., Pectasides, D., Dimopoulos, M.A. et al., Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications. Cancer Treat. Rev. 38:5 (2012), 473–483, 10.1016/j.ctrv.2011.09.002.
26. Schwarz, K., Siddiqi, N., Singh, S., Neil, C.J., Dawson, D.K., Frenneaux, M.P., The breathing heart- mitochondrial respiratory chain dysfunction in cardiac disease. Int. J. Cardiol. 171 (2014), 134–143, 10.1016/j.ijcard.2013.12.014.
27. Tang, X., Luo, X.Y., Chen, H.Z., Liu, D.P., Mitochondria, endothelial cell function, and vascular diseases. Front. Physiol., 5, 2014, 175, 10.3389/fphys.2014.00175.
28. Zorov, D.B., Juhaszova, M., Sollott, S.J., Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94 (2014), 909–950, 10.1152/physrev.00026.2013.
29. Hernandez-Mijares, A., Rocha, M., Rovira, S., Bañuls, C., Bellod, L., De Pablo, C. et al., Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care 36 (2013), 1695–1702, 10.2337/dc12-1224.
30. Natalicchio, A., Tortosa, F., Perrini, S., Laviola, L., Giorgino, F., p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress. Arch. Physiol. Biochem. 117:3 (2011), 116–124, 10.3109/13813455.2011.562513.
31. Orsini, F., Migliaccio, E., Moroni, M., Contursi, C., Raker, V.A., Piccini, D. et al., The life span determinant p66shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J. Biol. Chem. 279:24 (2004), 25689–25695, 10.1074/jbc.M401844200.
32. Giorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C. et al., Electron transfer between cytochrome c and p66shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122 (2005), 221–233, 10.1016/j.cell.2005.05.011.
33. Laviola, L., Orlando, M.R., Incalza, M.A., Caccioppoli, C., Melchiorre, M., Leonardini, A. et al., TNFα signals via p66(Shc) to induce E-selectin, promote leukocyte transmigration and enhance permeability in human endothelial cells. PLoS One, 8(12), 2013, e81930, 10.1371/journal.pone.0081930.
34. Pagnin, E., Fadini, G., de Toni, R., Tiengo, A., Calò L., Avogaro, A., Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells relationship to oxidative stress. J. Clin. Endocrinol. Metab. 90 (2005), 1130–1136, 10.1210/jc.2004-1283.
35. Menini, S., Amadio, L., Oddi, G., Ricci, C., Pesce, C., Pugliese, F. et al., Deletion of p66shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 55 (2006), 1642–1650, 10.2337/db05-1477.
36. Paneni, F., Costantino, S., Cosentino, F., p66shc-induced redox changes drive endothelial insulin resistance. Atherosclerosis 236 (2014), 426–429, 10.1016/j.atherosclerosis.2014.07.027.
37. Bedard, K., Krause, K.H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87:1 (2007), 245–313, 10.1152/physrev.00044.2005.
38. Panday, A., Sahoo, M.K., Orsorio, D., Batra, S., NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell. Mol. Immunol., 12, 2015, 523, 10.1038/cmi.2014.89.
39. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105 (2002), 1429–1435, 10.1161/01.CIR.0000012917.74432.66.
40. Datla, S.R., Peshavariya, H., Dusting, G.J., Mahadev, K., Goldstein, B.J., Jiang, F., Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 2319–2324.
41. Chen, F., Haigh, S., Barman, S., Fulton, D.J., From form to function: the role of Nox4 in the cardiovascular system. Front. Physiol., 3, 2012, 412, 10.3389/fphys.2012.00412.
42. Kim, Y.W., Byzova, T.V., Oxidative stress in angiogenesis and vascular disease. Blood 123 (2014), 625–631, 10.1182/blood-2013-09-512749.
43. Amara, N., Goven, D., Prost, F., Muloway, R., Crestani, B., Boczkowski, J., NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65 (2010), 733–738, 10.1136/thx.2009.113456.
44. Pache, J.C., Carnesecchi, S., Deffert, C., Donati, Y., Herrmann, F.R., Barazzone-Argiroffo, C. et al., NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis. Nat. Med. 17 (2011), 31–32, 10.1038/nm011-31.
45. Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 299:6 (2010), F1348–F1358, 10.1152/ajprenal.00028.2010.
46. Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J. et al., Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110 (2012), 1217–1225, 10.1161/CIRCRESAHA.112.267054.
47. Ray, R., Murdoch, C.E., Wang, M., Santos, C.X., Zhang, M., Alom-Ruiz, S. et al., Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 1368–1376, 10.1161/ATVBAHA.110.219238.
48. Touyz, R.M., Montezano, A.C., Vascular Nox4 a multifarious NADPH oxidase. Circ. Res. 110 (2012), 1159–1161, 10.1161/CIRCRESAHA.112.269068.
49. Sorescu, G.P., Song, H., Tressel, S.L., Hwang, J., Dikalov, S., Smith, D.A., Boyd, N.L. et al., Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ. Res. 95:8 (2004), 773–779, 10.1161/01.RES.0000145728.22878.45.
50. Honjo, T., Otsui, K., Shiraki, R., Kawashima, S., Sawamura, T., Yokoyama, M. et al., Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells. Endothelium 15:3 (2008), 137–141, 10.1080/1062332080232125433.
51. Drummond, G.R., Sobey, C.G., Endothelial NADPH oxidases: which NOX to target in vascular disease?. Trends Endocrinol. Metab. 25:9 (2014), 452–463, 10.1016/j.tem.2014.06.012.
52. Wind, S., Beuerlein, K., Armitage, M.E., Taye, A., Kumar, A.H., Janowitz, D. et al., Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56 (2010), 490–497, 10.1161/HYPERTENSIONAHA.109.149187.
53. Niu, X.L., Madamanchi, N.R., Vendrov, A.E., Tchivilev, I., Rojas, M., Madamanchi, C. et al., Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 121:4 (2010), 549–559, 10.1161/CIRCULATIONAHA.109.908319.
54. Wendt, M.C., Daiber, A., Kleschyov, A.L., Mülsch, A., Sydow, K., Schulz, E. et al., Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic. Biol. Med. 39:3 (2005), 381–391, 10.1016/freeradbiomed.2005.03.020.
55. Alderton, W.K., Cooper, C.E., Knowles, R.G., Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001), 593–615 (PMID:11463332, PubMed- indexed for MEDLINE).
56. Balligand, J.L., Feron, O., Dessy, C., eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol. Rev. 89:2 (2009), 481–534, 10.1152/physrev.00042.2007.
57. Alp, N.J., Channon, K.M., Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 24:3 (2004), 413–420, 10.1161/ATV.0000110785.96039.f6.
58. Diers, A.R., Broniowska, K.A., Hogg, N., Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells. Redox Biol. 1 (2013), 1–7, 10.1016/j.redox.2012.11.003.
59. Laursen, J.B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B.A. et al., Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:9 (2001), 1282–1288, 10.1161/01.CIR.103.9.1282.
60. Chalupsky, K., Cai, H., Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 102:25 (2005), 9056–9061, 10.1073/PNAS.0409594102.
61. Heitzer, T., Krohn, K., Albers, S., Meinertz, T., Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 43 (2000), 1435–1438, 10.1007/s001250051551.
62. Higashi, Y., Sasaki, S., Nakagawa, K., Fukuda, Y., Matsuura, H., Oshima, T. et al., Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am. J. Hypertens. 15 (2002), 326–332, 10.1016/S0895-7061(01)02317-2.
63. Stroes, E., Kastelein, J., Cosentino, F., Erkelens, W., Wever, R., Koomans, H. et al., Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 99 (1997), 41–46, 10.1172/JCI119131.
64. Sud, N., Wells, S.M., Wiseman, D.A., Wilham, J., Black, S.M., Symmetric dimethylarginine inhibits HSP90 activityin pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am. J. Phys. Cell Phys., 294(6), 2008, 10.1152/ajpcell.00384.2007.
65. Antoniades, C., Shirodaria, C., Leeson, P., Antonopoulos, A., Warrick, N., Van-Assche, T. et al., Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur. Heart J. 30:9 (2009), 1142–1150, 10.1093/eurheartj/ehp061.
66. Vergnani, L., Hatrik, S., Ricci, F., Passaro, A., Manzoli, N., Zuliani, G. et al., Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation 101:11 (2000), 1261–1266, 10.1161/01.CIR.101.11.1261.
67. Koshida, R., Ou, J., Matsunaga, T., Chilian, W.M., Oldham, K.T., Ackerman, A.W. et al., Angiostatin: a negative regulator of endothelial-dependent vasodilation. Circulation 107:6 (2003), 803–806, 10.1161/01.CIR.0000057551.88851.09.
68. Topal, G., Brunet, A., Millanvoye, E., Boucher, J.L., Rendu, F., Devynck, M.A. et al., Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic. Biol. Med. 36:12 (2004), 1532–1541, 10.1016/j.freeradbiomed.2004.03.019.
69. Cosentino, F., Hishikawa, K., Katusic, Z.S., Lüscher, T.F., High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:1 (1997), 25–28, 10.1161/01.CIR.96.1.25.
70. Zou, M.H., Shi, C., Cohen, R.A., Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109:6 (2002), 817–826, 10.1172/JCI14442.
71. Thum, T., Fraccarollo, D., Schultheiss, M., Froese, S., Galuppo, P., Widder, J.D. et al., Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56 (2007), 666–674, 10.2337/db06-0699.
72. Kuwabara, Y., Nishino, T., Okamoto, K., Matsumura, T., Eger, B.T., Pai, E.F. et al., Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductase. Proc. Natl. Acad. Sci. U. S. A. 100:14 (2003), 8170–8175, 10.1073/pnas.1431485100.
73. Nishino, T., Okamoto, K., Eger, B.T., Pai, E.F., Nishino, T., Mammalian xanthine oxidoreductase- mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 275 (2008), 3278–3289, 10.1111/j.1742-4658.2008.06489.x.
74. Nishino, T., Okamoto, K., Kawaguchi, Y., Hori, H., Matsumura, T., Eger, B.T. et al., Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant. J. Biol. Chem. 280 (2005), 24888–24894, 10.1074/jbc.M501830200.
75. Jankov, R.P., Kantores, C., Pan, J., Belik, J., Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats. Am. J. Phys. Lung Cell. Mol. Phys. 294 (2008), L233–L245, 10.1152/ajplung.00166.2007.
76. Desco, M.C., Asensi, M., Màrquez, R., Martìnez-Valls, J., Vento, M., Pallardo, F.V. et al., Xanthine oxidase is involved in free radical production in type 1 diabetes. Diabetes 51 (2002), 1118–1124, 10.2337/diabetes.51.4.1118.
77. Kuppusamy, U.R., Indran, M., Rokiah, P., Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabet. Med. 22 (2005), 1343–1346, 10.1111/j.1464-5491.2005.01630.x.
78. McNally, J.S., Davis, M.E., Giddens, D.P., Saha, A., Hwang, J., Dikalov, S. et al., Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 285 (2003), H2290–H2297, 10.1152/ajpheart.00515.2003.
79. Landmesser, U., Spiekermann, S., Preuss, C., Sorrentino, S., Fischer, D., Manes, C. et al., Angiotensin ii induces endothelial xanthine oxidase activation. Role for endothelial dysfunction in patients with coronary disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 943–948, 10.1161/01.ATV.0000258415.32883.bf.
80. Battelli, M.G., Bolognesi, A., Polito, L., Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. Biochim. Biophys. Acta 1842:9 (2014), 1502–1517, 10.1016/j.bbadis.2014.05.022.
81. Kelley, E.E., Hock, T., Khoo, N.K., Richardson, G.R., Johnson, K.K., Powell, P.C. et al., Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic. Biol. Med. 40:6 (2006), 952–959, 10.1016/j.freeradbiomed.2005.11.008.
82. Adachi, T., Fukushima, T., Usami, Y., Hirano, K., Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial cell surface. Biochem. J. 289:Pt 2 (1993), 523–527, 10.1042/bj2890523.
83. Farquharson, C., Butler, R., Hill, A., Belch, J.J., Struthers, A.D., Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106 (2002), 221–226, 10.1161/01.CIR.0000022140.61460.1D.
84. Butler, R., Morris, A.D., Belch, J.J., Hill, A., Struthers, A.D., Allopurinol normalizes endothelial dysfunction in Type 2 diabetics with mild hypertension. Hypertension 35:3 (2000), 746–751, 10.1161/01.HYP.35.3.746.
85. Fukai, T., Folz, R.J., Landmesser, U., Harrison, D.G., Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 55:2 (2002), 239–249, 10.1016/S0008-6363(02)00328-0.
86. Foresman, E.L., Miller, F.J. Jr., Extracellular but not cytosolic superoxide dismutase protects against oxidant-mediated endothelial dysfunction. Redox Biol. 1 (2013), 292–296, 10.1016/j.redox.2013.04.003.
87. Juarez, J.C., Manuia, M., Burnett, M.E., Betancourt, O., Boivin, B., Shaw, D.E. et al., Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U. S. A. 105:20 (2008), 7147–7152, 10.1073/pnas.0709451105.
88. Morikawa, K., Shimokawa, H., Matoba, T., Kubota, H., Akaike, T., Talukder, M.A. et al., Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J. Clin. Invest. 112:12 (2003), 1871–1879, 10.1172/JCI19351.
89. Dromparis, P., Michelakis, E.D., Mitochondria in vascular health and disease. Annu. Rev. Physiol. 75 (2013), 95–126, 10.1146/annurev-physiol-030212-183804.
90. Connor, K.M., Subbaram, S., Regan, K.J., Nelson, K.K., Mazurkiewicz, J.E., Bartholomew, P.J. et al., Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 280:17 (2005), 16916–16924, 10.1074/jbc.M410690200.
91. He, T., Peterson, T.E., Holmuhamedov, E.L., Terzic, A., Caplice, N.M., Oberley, L.W. et al., Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler. Thromb. Vasc. Biol. 24:11 (2004), 2021–2027, 10.1161/01.ATV.0000142810.27849.8f.
92. Ohashi, M., Runge, M.S., Faraci, F.M., Heistad, D.D., MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26:10 (2006), 2331–2336, 10.1161/01.ATV.0000238347.77590.c9.
93. Afolayan, A.J., Eis, A., Teng, R.J., Bakhutashvili, I., Kaul, S., Davis, J.M. et al., Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn. Am. J. Phys. Lung Cell. Mol. Phys. 303:10 (2012), L870–L879, 10.1152/ajplung.00098.2012.
94. Marrotte, E.J., Chen, D.D., Hakim, J.S., Chen, A.F., Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J. Clin. Invest. 120:12 (2010), 4207–4219, 10.1172/JCI36858.
95. Fukai, T., Ushio-Fukai, M., Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid. Redox Signal. 15:6 (2011), 1583–1606, 10.1089/ars.2011.3999.
96. Brown, K.A., Chu, Y., Lund, D.D., Heistad, D.D., Faraci, F.M., Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am. J. Physiol. Heart Circ. Physiol. 290:6 (2006), H2600–H2605, 10.1152/ajpheart.00676.2005.
97. Fennell, J.P., Brosnan, M.J., Frater, A.J., Hamilton, C.A., Alexander, M.Y., Nicklin, S.A. et al., Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther. 9:2 (2002), 110–117, 10.1038/sj.gt.3301633.
98. Iida, S., Chu, Y., Francis, J., Weiss, R.M., Gunnett, C.A., Faraci, F.M. et al., Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 289:2 (2005), H525–H532, 10.1152/ajpheart.00108.2005.
99. Hwang, I., Lee, J., Huh, J.Y., Park, J., Lee, H.B., Ho, Y.S. et al., Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61:3 (2012), 728–738, 10.2337/db11-0584.
100. Meilhac, O., Zhou, M., Santanam, N., Parthasarathy, S., Lipid peroxides induce expression of catalase in cultured vascular cells. J. Lipid Res. 41:8 (2000 Aug), 1205–1213 (PMID: 10946007, PubMed- indexed for MEDLINE).
101. Forgione, M.A., Weiss, N., Heydrick, S., Cap, A., Klings, E.S., Bierl, C. et al., Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 282:4 (2002), H1255–H1261, 10.1152/ajpheart.00598.2001.
102. Zhang, Y., Handy, D.E., Loscalzo, J., Adenosine dependent induction of glutathione peroxidase 1 in human primary endothelial cells and protection against oxidative stress. Circ. Res., 96(8), 2005, 8317, 10.1161/01.RES.0000164401.21929.CF.
103. Oelze, M., KröllerSchön, S., Steven, S., Lubos, E., Doppler, C., Hausding, M. et al., Glutathione peroxidase1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in aging. Hypertension 63:2 (2014), 390–396.
104. La Sala, L., Cattaneo, M., De Nigris, V., Pujadas, G., Testa, R., Bonfigli, A.R. et al., Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells. Cardiovasc. Diabetol., 15, 2016, 71, 10.1186/s12933-016-0390-9.
105. Rhee, S.G., Chae, H.Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38:12 (2005), 1543–1552, 10.1016/j.freeradbiomed.2005.02.026.
106. Manevich, Y., Sweitzer, T., Pak, J.H., Feinstein, S.I., Muzykantov, V., Fisher, A.B., 1Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation mediated membrane damage. Proc. Natl. Acad. Sci. U. S. A. v99:18 (2002), 11599–11604, 10.1073/pnas.182384499.
107. Wang, Y., Manevich, Y., Feinstein, S.I., Fisher, A.B., Adenovirus-mediated transfer of the 1cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am. J. Phys. Lung Cell. Mol. Phys. 286:6 (2004), L1188–L1193, 10.1152/ajplung.00288.2003.
108. Pak, J.H., Manevich, Y., Kim, H.S., Feinstein, S.I., Fisher, A.B., An antisense oligonucleotide to 1cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J. Biol. Chem. 277:51 (2002), 49927–49934, 10.1074/jbc.M204222200.
109. Kang, D.H., Lee, D.J., Lee, K.W., Park, Y.S., Lee, J.Y., Lee, S.H. et al., Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol. Cell 44:4 (2011), 545–558, 10.1016/j.molcel.2011.08.040.
110. Kümin, A., Schäfer, M., Epp, N., Bugnon, P., Born-Berclaz, C., Oxenius, A. et al., Peroxiredoxin 6 is required for blood vessel integrity in wounded skin. J. Cell Biol. 179:4 (2007), 747–760, 10.1083/jcb.200706090.
111. Mowbray, A.L., Kang, D.H., Rhee, S.G., Kang, S.W., Jo, H., Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells: PRX 1 as a mechanosensitive antioxidant. J. Biol. Chem. 283:3 (2008), 1622–1627, 10.1074/jbc.M707985200.
112. Haendeler, J., Popp, R., Goy, C., Tischler, V., Zeiher, A.M., Dimmeler, S., Cathepsin D and H2O2 stimulate degradation of thioredoxin-1: implication for endothelial cell apoptosis. Biol. Chem. 280:52 (2005), 42945–42951, 10.1074/jbc.M506985200.
113. Yamawaki, H., Pan, S., Lee, R.T., Berk, B.C., Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J. Clin. Invest. 115:3 (2005), 733–738, 10.1172/JCI23001.
114. Schroeder, P., Popp, R., Wiegand, B., Altschmied, J., Haendeler, J., Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells–important role for nuclear thioredoxin-1. Arterioscler. Thromb. Vasc. Biol. 27:11 (2007), 2325–2331, 10.1161/ATVBAHA.107.149419.
115. Devarajan, A., Bourquard, N., Hama, S., Navab, M., Grijalva, V.R., Morvardi, S. et al., Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid. Redox Signal. 14:3 (2011), 341–351, 10.1089/ars.2010.3430.
116. Ng, C.J., Bourquard, N., Grijalva, V., Hama, S., Shih, D.M., Navab, M. et al., Paraoxonase2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase2. J. Biol. Chem. 281:40 (2006), 29491–29500, 10.1074/jbc.M605379200.
117. Cui, Y., Xu, X., Bi, H., Zhu, Q., Wu, J., Xia, X. et al., Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp. Eye Res. 83:4 (2006), 807–816, 10.1016/j.exer.2006.03.024.
118. Duval, C., Nègre-Salvayre, A., Dogilo, A., Salvayre, R., Pénicaud, L., Casteilla, L., Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem. Cell Biol. 80:6 (2002), 757–764, 10.1139/O02-158.
119. Sun, J., Pu, Y., Wang, P., Chen, S., Zhao, Y., Liu, C. et al., TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction. Cardiovasc. Diabetol., 12, 2013, 69, 10.1186/1475-2840-12-69.
120. Lee, K.U., Lee, I.K., Han, J., Song, D.K., Kim, Y.M., Song, H.S. et al., Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ. Res. 96:11 (2005), 1200–1207.
121. Kluge, M.A., Fetterman, J.L., Vita, J.A., Mitochondria and endothelial function. Circ. Res. 112:8 (2013), 1171–1188, 10.1161/CIRCRESAHA.111.300233.
122. Potashnik, R., Bloch-Damti, A., Bashan, N., Rudich, A., IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia 46:5 (2003), 639–648, 10.1007/s00125-003-1097-5.
123. Tesfamariam, B., Brown, M.L., Cohen, R.A., Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87:5 (1991), 1643–1648, 10.1172/JCI115179.
124. Sheetz, M.J., King, G.L., Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:20 (2002), 2579–2588, 10.1001/jama.288.20.2579.
125. Lebiedzinska, M., Karkucinska-Wieckowska, A., Giorgi, C., Karczmarewicz, E., Pronicka, E., Pinton, P. et al., Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders. Biochim. Biophys. Acta 197:6–7 (2010), 952–960, 10.1016/j.bbabio.2010.03.005.
126. Pinton, P., Rizzuto, R., p66Shc, oxidative stress and aging. Cell Cycle 7:3 (2008), 304–308, 10.4161/cc.7.3.5360.
127. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414:6865 (2001), 813–820, 10.1038/414813a.
128. Fu, M.X., Requena, J.R., Jenkins, A.J., Lyons, T.J., Baynes, J.W., Thorpe, S.R., The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:17 (1996), 9982–9986, 10.1074/jbc.271.17.9982.
129. Thornalley, P.J., Langborg, A., Minhas, H.S., Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344:Pt 1 (1999), 109–116, 10.1042/bj3440109.
130. Wells-Knecht, K.J., Zyzak, D.V., Litchfield, J.E., Thorpe, S.R., Baynes, J.W., Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34:11 (1995), 3702–3709 (PMID: 7893666, PubMed - indexed for MEDLINE).
131. Scheijen, J.L., Schalkwijk, C.G., Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen. Clin. Chem. Lab. Med. 52:1 (2014), 85–91, 10.1515/cclm-2012-0878.
132. Goldin, A., Beckman, J.A., Schmidt, A.M., Creager, M.A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:6 (2006), 597–605, 10.1161/CIRCULATIONAHA.106.621854.
133. Ishibashi, Y., Matsui, T., Takeuchi, M., Yamagishi, S., Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression. Biochem. Biophys. Res. Commun. 391:3 (2010), 1405–1408, 10.1016/j.bbrc.2009.12.075.
134. Phalitakul, S., Okada, M., Hara, Y., Yamawaki, H., Vaspin prevents methylglyoxal-induced apoptosis in human vascular endothelial cells by inhibiting reactive oxygen species generation. Acta Physiol. (Oxford) 209:3 (2013), 212–219, 10.1111/apha.12139.
135. Zhan, Y., Sun, H.L., Chen, H., Zhang, H., Sun, J., Zhang, Z. et al., Glucagonlike peptide-1(GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)induced apoptosis. Med. Sci. Monit. 18:7 (2012), BR286–BR291, 10.12659/MSM.883207.
136. Chu, P., Han, G., Ahsan, A., Sun, Z., Liu, S., Zhang, Z. et al., Phosphocreatine protects endothelial cells from Methylglyoxal induced oxidative stress and apoptosis via the regulation of PI3K/Akt/eNOS and NF-κB pathway. Vasc. Pharmacol. pii:16 (2016), 30106–30109 S1537-1891 10.1016/j.vph.2016.08.01.
137. Wu, Q., Zhao, Y., Duan, W., Liu, Y., Chen, X., Zhu, M., Propofol inhibits high glucose-induced PP2A expression in human umbilical vein endothelial cells. Vasc. Pharmacol., 2017, S1537–S1891, 10.1016/j.vph.2017.02.002.
138. Weigert, C., Brodbeck, K., Staiger, H., Kausch, C., Machicao, F., Häring, H.U. et al., Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J. Biol. Chem. 279:23 (2004), 23942–23952 10.1074/jbc.M312692200.
139. Kim, F., Tysseling, K.A., Rice, J., Pham, M., Haji, L., Gallis, B.M. et al., Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler. Thromb. Vasc. Biol. 25:5 (2005), 989–994, 10.1161/01.ATV.0000160549.60980.a8.
140. Maloney, E., Sweet, I.R., Hockenbery, D.M., Pham, M., Rizzo, N.O., Tateya, S. et al., Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler. Thromb. Vasc. Biol. 29:9 (2009), 1370–1375, 10.1161/ATVBAHA.109.188813.
141. Choi, S.E., Kang, Y., Jang, H.J., Shin, H.C., Kim, H.E., Kim, H.S. et al., Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis. J. Vasc. Res. 44:5 (2007), 365–374, 10.1159/000102321.
142. Chai, W., Liu, Z., p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kappaB degradation in human coronary artery endothelial cells. Endocrinology 148:4 (2007), 1622–1628, 10.1210/en.2006-1068.
143. Erdogdu, O., Eriksson, L., Xu, H., Sjöholm, A., Zhang, Q., Nyström, T., Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways. J. Mol. Endocrinol. 50:2 (2013), 229–241, 10.1530/JME-12-0166.
144. Jiang, H., Liang, C., Liu, X., Jiang, Q., He, Z., Wu, J. et al., Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways. Atherosclerosis 210:1 (2010), 71–77, 10.1016/j.atherosclerosis.2009.10.032.
145. Holland, W.L., Summers, S.A., Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 29:4 (2008), 381–402, 10.1210/er.2007-0025.
146. Zhang, D.X., Zou, A.P., Li, P.L., Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 284:2 (2003), H605–H612, 10.1152/ajpheart.00697.2002.
147. Li, H., Junk, P., Huwiler, A., Burkhardt, C., Wallerath, T., Pfeilschifter et al., Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation 106:17 (2002), 2250–2256, 10.1161/01.CIR.0000035650.05921.50.
148. Li, C., Zhou, J., Wang, A., Li, N., Chen, B., Lei, M., Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract. 93 (2011), 77–85, 10.1016/j.diabres.2011.03.017.
149. Naik, E., Dixit, V.M., Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 208:3 (2011), 417–420, 10.1084/jem.20110367.
150. Martinon, F., Major, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2008), 229–265, 10.1146/annurev.immunol.021908.132715.
151. Anderson, P., Post­transcriptional regulation of tumour necrosis factor alpha production. Ann. Rheum. Dis. 59 (2000), i3–i5, 10.1136/ard.59.suppl_1.i3.
152. DiMauro, S., Schon, E.A., Mitochondrial respiratory­chain diseases. N. Engl. J. Med. 348 (2003), 2656–2668, 10.1056/NEJMra022567.
153. Nisoli, E., Clementi, E., Carruba, M.O., Moncada, S., Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?. Circ. Res. 100 (2007), 795–806, 10.1161/01.RES.0000259591.97107.6c.
154. Patti, M.-E., Corvera, S., The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr. Rev. 31 (2010), 364–395, 10.1210/er.2009­0027.
155. Schroder, K., Tschopp, J., The inflammasomes. Cell 140:6 (2010), 821–832, 10.1016/j.cell.2010.01.040.
156. Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T. et al., NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 4 (2015), 296–307, 10.1016/j.redox.2015.01.008.
157. Binder, C.J., Chang, M.K., Shaw, P.X., Miller, Y.I., Hartvigsen, K., Dewan, A. et al., Innate and acquired immunity in atherogenesis. Nat. Med. 8:11 (2002), 1218–1226, 10.1038/nm1102-121812411948.
158. Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:16 (2005), 1685–1695, 10.1056/NEJMra043430.
159. Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J. et al., AtheroGene investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106:1 (2002), 24–30, 10.1161/01.CIR.000002054630940.9212093765.
160. Mallat, Z., Corbaz, A., Scoazec, A., Besnard, S., Lesèche, G., Chvatchko, Y. et al., Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104:14 (2001), 1598–1603, 10.1161/hc3901.09672111581135.
161. Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S.E., Holt, C.M., Interleukin-1beta in coronary arteries of patients with ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 16:8 (1996), 1000–1006, 10.1161/01.ATV.16.8.10008696938.
162. Moyer, C.F., Sajuthi, D., Tulli, H., Williams, J.K., Synthesis of IL-1alpha and IL-1beta by arterial cells in atherosclerosis. Am. J. Pathol. 138:4 (1991), 951–960 (2012178. PMID: 2012178 PubMed- indexed for MEDLINE).
163. Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V., Boldin, M.P., Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17 (1999), 331–367, 10.1146/annurev.immunol.17.1.331.
164. Karsan, A., Yee, E., Harlan, J.M., Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271:44 (1996 Nov 1), 27201–27204, 10.1074/jbc.271.44.27201 (PMID: 8910286 PubMed- indexed for MEDLINE).
165. van der Poll, T., Lowry, S.F., Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?. Shock 3:1 (1995), 1–12 (PMID: 7850574 PubMed - indexed for MEDLINE).
166. Goossens, V., Grooten, J., De Vos, K., Fiers, W., Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 92:18 (1995 Aug 29), 8115–8119 (PMID: 7667254 PubMed - indexed for MEDLINE).
167. Schütze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., Krönke, M., TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown. Cell 71:5 (1992), 765–776, 10.1016/0092-8674(92)90553-O.
168. Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., Fiers, W., Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:8 (1993), 3095–3104 (PMID: 8344250 PubMed- indexed for MEDLINE).
169. Corda, S., Laplace, C., Vicaut, E., Duranteau, J., Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am. J. Respir. Cell Mol. Biol. 24:6 (2001), 762–768, 10.1165/ajrcmb.24.6.4228.
170. García-Ruiz, C., Colell, A., Marí M., Morales, A., Fernández-Checa, J.C., Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272:17 (1997), 11369–11377 (PMID: 9111045 PubMed - indexed for MEDLINE).
171. Zhang, D.X., Yi, F.X., Zou, A.P., Li, P.L., Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 283:5 (2002), H1785–H1794, 10.1152/ajpheart.00318.2002.
172. Böse, D., Leineweber, K., Konorza, T., Zahn, A., Bröcker-Preuss, M., Mann, K. et al., Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am. J. Physiol. Heart Circ. Physiol. 292:5 (2007), H2295–H2299, 10.1152/ajpheart.01116.2006.
173. Rowlands, D.J., Islam, M.N., Das, S.R., Huertas, A., Quadri, S.K., Horiuchi, K. et al., Activation of TNFR1 ectodomain shedding by mitochondrial Ca2 + determines the severity of inflammation in mouse lung microvessels. J. Clin. Invest. 121:5 (2011), 1986–1999, 10.1172/JCI43839.
174. Li, X., Fang, P., Mai, J., Choi, E.T., Wang, H., Yang, X.F., Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J. Hematol. Oncol., 6, 2013 Feb 25, 19, 10.1186/1756-8722-6-19.
175. Ouchi, N., Parker, J.L., Lugus, J.J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11:2 (2011), 85–97, 10.1038/nri2921.
176. Yamagishi, S.I., Edelstein, D., Du, X.L., Kaneda, Y., Guzmán, M., Brownlee, M., Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 276:27 (2001), 25096–25100, 10.1074/jbc.M007383200.
177. Chen, C., Jiang, J., Lü J.M., Chai, H., Wang, X., Lin, P.H. et al., Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 299:1 (2010), H193–H201, 10.1152/ajpheart.00431.2009.
178. Woodfin, A., Voisin, M.B., Nourshargh, S., Recent developments and complexities in neutrophil transmigration. Curr. Opin. Hematol. 17:1 (2010), 9–17, 10.1097/MOH.0b013e3283333930.
179. Zarbock, A., Ley, K., McEver, R.P., Hidalgo, A., Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118:26 (2011), 6743–6751, 10.1182/blood-2011-07-343566.
180. Haraldsen, G., Kvale, D., Lien, B., Farstad, I.N., Brandtzaeg, P., Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol. 156:7 (1996), 2558–2565 (PMID: 8786319 PubMed- indexed for MEDLINE).
181. Griffin, G.K., Newton, G., Tarrio, M.L., Bu, D.X., Maganto-Garcia, E., Azcutia, V. et al., IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J. Immunol. 188:12 (2012), 6287–6299, 10.4049/jimmunol.1200385.
182. Hafezi-Moghadam, A., Thomas, K.L., Prorock, A.J., Huo, Y., Ley, K.J., L-selectin shedding regulates leukocyte recruitment. Exp. Med. 193:7 (2001), 863–872 (PMID: 11283159 PubMed- indexed for MEDLINE).
183. Moore, K.L., Eaton, S.F., Lyons, D.E., Lichenstein, H.S., Cummings, R.D., McEver, R.P., The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J. Biol. Chem. 269:37 (1994), 23318–23327 (PMID: 7521878 PubMed- indexed for MEDLINE).
184. Steegmaier, M., Levinovitz, A., Isenmann, S., Borges, E., Lenter, M., Kocher, H.P. et al., The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature 373:6515 (1995), 615–620, 10.1038/373615a0.
185. Zarbock, A., Ley, K., McEver, R.P., Hidalgo, A., Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118:26 (2011), 6743–6751, 10.1182/blood-2011-07-343566.
186. Evans, R., Patzak, I., Svensson, L., De Filippo, K., Jones, K., McDowall, A. et al., Integrins in immunity. J. Cell Sci. 122:Pt 2 (2009), 215–225, 10.1242/jcs.019117.
187. Zarbock, A., Deem, T.L., Burcin, T.L., Ley, K., Galphai2 is required for chemokine-induced neutrophil arrest. Blood 110:10 (2007), 3773–3779, 10.1182/blood-2007-06-094565.
188. Phillipson, M., Heit, B., Colarusso, P., Liu, L., Ballantyne, C.M., Kubes, P., Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J. Exp. Med. 203:12 (2006), 2569–2575, 10.1084/jem.20060925.
189. Borregaard, N., Neutrophils, from marrow to microbes. Immunity 33:5 (2010), 657–670, 10.1016/j.immuni.2010.11.011.
190. Mamdouh, Z., Chen, X., Pierini, L.M., Maxfield, F.R., Muller, W.A., Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 421:6924 (2003), 748–753, 10.1038/nature01300.
191. Bixel, M.G., Petri, B., Khandoga, A.G., Khandoga, A., Wolburg-Buchholz, K., Wolburg, H. et al., A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. Blood 109:12 (2007), 5327–5336, 10.1182/blood-2006-08-043109.
192. Patel, K.D., Zimmerman, G.A., Prescott, S.M., McEver, R.P., McIntyre, T.M., Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112:4 (1991 Feb), 749–759 (PMID: 1704376 PubMed- indexed for MEDLINE).
193. Gaboury, J.P., Anderson, D.C., Kubes, P., Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. Am. J. Phys. 266:2 Pt 2 (1994), H637–H642 (PMID: 7908174 PubMed- indexed for MEDLINE).
194. Narayanan, S. et al., Ann. Clin. Lab. Sci. 29:4 (1999), 275–280 (PMID: 10528826 PubMed- indexed for MEDLINE).
195. Sugama, Y., Tiruppathi, C., Offakidevi, K., Andersen, T.T., Fenton, J.W. 2nd, Malik, A.B., Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol. 119:4 (1992), 935–944 (PMID: 1385447 PubMed- indexed for MEDLINE).
196. Roebuck, K.A., Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (review). Int. J. Mol. Med. 4:3 (1999), 223–230, 10.3892/ijmm.4.3.223.
197. Ferran, C., Millan, M.T., Csizmadia, V., Cooper, J.T., Brostjan, C., Bach, F.H. et al., Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Commun. 214:1 (1995), 212–223, 10.1006/bbrc.1995.2277.
198. Ikeda, M., Schroeder, K.K., Mosher, L.B., Woods, C.W., Akeson, A.L., Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes. J. Invest. Dermatol. 103:6 (1994), 791–796, 10.1111/1523-1747.ep12413176.
199. Lo, S.K., Janakidevi, K., Lai, L., Malik, A.B., Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Phys. 264:4 Pt 1 (1993), L406–L412 (PMID: 7682787 PubMed- indexed for MEDLINE).
200. Griendling, K.K., Sorescu, D., Ushio-Fukai, M., NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:5 (2000), 494–501, 10.1161/01.RES.86.5.494.
201. Fan, J., Frey, R.S., Rahman, A., Malik, A.B., Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha-induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J. Biol. Chem. 277:5 (2002), 3404–3411, 10.1074/jbc.M110054200.
202. Chen, X.L., Zhang, Q., Zhao, R., Ding, X., Tummala, P.E., Medford, R.M., Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells. J. Pharmacol. Exp. Ther. 305:2 (2003), 573–580, 10.1124/jpet.102.047894.
203. Gertzberg, N., Neumann, P., Rizzo, V., Johnson, A., NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am. J. Phys. Lung Cell. Mol. Phys. 286:1 (2004), L37–L48, 10.1152/ajplung.00116.2003.
204. Li, J.M., Fan, L.M., Christie, M.R., Shah, A.M., Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol. Cell. Biol. 25:6 (2005), 2320–2330, 10.1128/MCB.25.6.2320-2330.2005.
205. Souza, H.P., Frediani, D., Cobra, A.L., Moretti, A.I., Jurado, M.C., Fernandes, T.R. et al., Angiotensin II modulates CD40 expression in vascular smooth muscle cells. Clin. Sci. (Lond.) 116:5 (2009), 423–431, 10.1042/CS2008015.
206. Hernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M. et al., Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:6 (1997), 1532–1541, 10.1161/01.CIR.95.6.1532.
207. Hernández-Presa, M.A., Bustos, C., Ortego, M., Tuñón, J., Ortega, L., Egido, J., ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am. J. Pathol. 153:6 (1998), 1825–1837 (PMID: 9846973 PubMed- indexed for MEDLINE).
208. Muller, D.N., Mervaala, E.M., Schmidt, F., Park, J.K., Dechend, R., Genersch, E. et al., Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension 36:2 (2000), 282–290, 10.1161/01.HYP.36.2.282.
209. Libby, P., Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am. J. Cardiol. 86:8B (2000), 3J–8J, 10.1016/S0002-9149(00)01339-4 discussion 8J–9J.
210. Costanzo, A., Moretti, F., Burgio, V.L., Bravi, C., Guido, F., Levrero, M., Puri, P.L., Endothelial activation by angiotensin II through NFkappaB and p38 pathways: involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J. Cell. Physiol. 195:3 (2003), 402–410, 10.1002/jcp.10191.
211. Liu, J.Q., Zelko, I.N., Folz, R.J., Reoxygenation-induced constriction in murine coronary arteries: the role of endothelial NADPH oxidase (gp91phox) and intracellular superoxide. J. Biol. Chem. 279:23 (2004), 24493–24497, 10.1074/jbc.M402920200.
212. Pastore, L., Tessitore, A., Martinotti, S., Toniato, E., Alesse, E., Bravi, M.C. et al., Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 100:15 (1999), 1646–1652, 10.1161/01.CIR.100.15.1646.
213. Hwang, J., Saha, A., Boo, Y.C., Sorescu, G.P., McNally, J.S., Holland, S.M. et al., Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J. Biol. Chem. 278:47 (2003), 47291–47298, 10.1074/jbc.M305150200.
214. Cho, R.L., Yang, C.C., Lee, I.T., Lin, C.C., Chi, P.L., Hsiao, L.D. et al., Lipopolysaccharide induces ICAM-1 expression via a c-Src/NADPH oxidase/ROS-dependent NF-κB pathway in human pulmonary alveolar epithelial cells. Am. J. Phys. Lung Cell. Mol. Phys. 310:7 (2016), L639–L657, 10.1152/ajplung.00109.2014.
215. Lee, I.T., Shih, R.H., Lin, C.C., Chen, J.T., Yang, C.M., Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells. Cell Commun. Signal, 10(1), 2012, 33, 10.1186/1478-811X-10-33.
216. Kunsch, C., Medford, R.M., Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85:8 (1999), 753–766, 10.1161/01.RES.85.8.753 10521248.
217. Cominacini, L., Pasini, A.F., Garbin, U., Davoli, A., Tosetti, M.L., Campagnola, M. et al., Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 275:17 (2000), 12633–12638 (PMID: 10777555 PubMed- indexed for MEDLINE).
218. Cominacini, L., Garbin, U., Pasini, A.F., Davoli, A., Campagnola, M., Contessi, G.B. et al., Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic. Biol. Med. 22:1–2 (1997), 117–127, 10.1016/S0891-5849(96)00271-7.
219. Khan, B.V., Parthasarathy, S.S., Alexander, R.W., Medford, R.M., Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:3 (1995), 1262–1270, 10.1172/JCI117776.
220. Chen, C.Y., Yi, L., Jin, X., Zhang, T., Fu, Y.J., Zhu, J.D. et al., Inhibitory effect of delphinidin on monocyte-endothelial cell adhesion induced by oxidized low-density lipoprotein via ROS/p38MAPK/NF-κB pathway. Cell Biochem. Biophys. 61:2 (2011), 337–348, 10.1007/s12013-011-9216-2.
221. Stielow, C., Catar, R.A., Muller, G., Wingler, K., Scheurer, P., Schmidt, H.H. et al., Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem. Biophys. Res. Commun. 344:1 (2006), 200–205, 10.1016/j.bbrc.2006.03.114.
222. Ylä-Herttuala, S., Rosenfeld, M.E., Parthasarathy, S., Sigal, E., Särkioja, T., Witztum, J.L. et al., Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87:4 (1991), 1146–1152, 10.1172/JCI115111.
223. Reilly, K.B., Srinivasan, S., Hatley, M.E., Patricia, M.K., Lannigan, J., Bolick, D.T. et al., 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J. Biol. Chem. 279:10 (2004), 9440–9450, 10.1074/jbc.M303857200.
224. Wölle, J., Welch, K.A., Devall, L.J., Cornicelli, J.A., Saxena, U., Transient overexpression of human 15-lipoxygenase in aortic endothelial cells enhances tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression. Biochem. Biophys. Res. Commun. 220:2 (1996), 310–314, 10.1006/bbrc.1996.0402.
225. Folcik, V.A., Aamir, R., Cathcart, M.K., Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler. Thromb. Vasc. Biol. 17:10 (1997), 1954–1961, 10.1161/01.ATV.17.10.1954.
226. Sukhanov, S., Snarski, P., Vaughn, C., Lobelle-Rich, P., Kim, C., Higashi, Y. et al., Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase. Atherosclerosis 238:2 (2015), 313–320, 10.1016/j.atherosclerosis.2014.12.024.
227. Gustavsson, C., Agardh, C.D., Zetterqvist, A.V., Nilsson, J., Agardh, E., Gomez, M.F., Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One, 5(9), 2010, e12699, 10.1371/journal.pone.0012699.
228. Gearing, A.J., Newman, W., Circulating adhesion molecules in disease. Immunol. Today 14:10 (1993), 506–512, 10.1016/0167-5699(93)90267-O.
229. Pigott, R., Dillon, L.P., Hemingway, I.H., Gearing, A.J., Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187:2 (1992), 584–589, 10.1016/0006-291X(92)91234-H.
230. Marfella, Esposito K., Giunta, R., Coppola, G., De Angelis, L., Farzati, B. et al., Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 101:19 (2000), 2247–2251, 10.1161/01.CIR.101.19.2247.
231. Boulbou, M.S., Koukoulis, G.N., Makri, E.D., Petinaki, E.A., Gourgoulianis, K.I., Germenis, A.E., Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int. J. Cardiol. 98:1 (2005), 39–44, 10.1016/j.ijcard.2003.07.037.
232. Jude, E.B., Douglas, J.T., Anderson, S.G., Young, M.J., Boulton, A.J., Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. Eur. J. Intern. Med. 13:3 (2002), 185–189, 10.1016/S0953-6205(02)00014-6.
233. Blankenberg, S., Barbaux, S., Tiret, L., Adhesion molecules and atherosclerosis. Atherosclerosis 170:2 (2003), 191–203, 10.1016/S0021-9150(03)00097-2.
234. Song, Y., Manson, J.E., Tinker, L., Rifai, N., Cook, N.R., Hu, F.B. et al., Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 56:7 (2007), 1898–1904, 10.2337/db07-0250.
235. Shalia, K.K., Mashru, M.R., Vasvani, J.B., Mokal, R.A., Mithbawkar, S.M., Thakur, P.K., Circulating levels of cell adhesion molecules in hypertension. Indian J. Clin. Biochem. 24:4 (2009), 388–397, 10.1007/s12291-009-0070-6.
236. Vallance, P., Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 358:9299 (2001 Dec 22–29), 2096–2097, 10.1016/S0140-6736(01)07229-4.
237. Bonetti, P.O., Lerman, L.O., Lerman, A., Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23:2 (2003), 168–175, 10.1161/01.ATV.0000051384.43104.
238. Sena, C.M., Pereira, A.M., Seiça, R., Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim. Biophys. Acta 1832:12 (2013), 2216–2231, 10.1016/j.bbadis.2013.08.006.
239. Dhananjayan, R., Koundinya, K.S., Malati, T., Kutala, V.K., Endothelial dysfunction in type 2 diabetes mellitus. Indian J. Clin. Biochem. 31:4 (2016), 372–379, 10.1007/s12291-015-0516-y.
240. Verma, S., Anderson, T.J., Fundamentals of endothelial function for the clinical cardiologist. Circulation 105:5 (2002), 546–549, 10.1161/hc0502.104540.
241. Mombouli, J.V., Vanhoutte, P.M., Endothelial dysfunction: from physiology to therapy. J. Mol. Cell. Cardiol. 31:1 (1999), 61–74, 10.1006/jmcc.1998.0844.
242. Furchgott, R.F., Albert Lasker medical research awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 276:14 (1996), 1186–1188, 10.1161/CIRCRESAHA.113.301577.
243. De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, M.A.J. et al., Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. Clin. Investig. 96:1 (1995), 60–68, 10.1172/JCI118074.
244. Zeiher, A.M., Fisslthaler, B., Schray-Utz, B., Busse, R., Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76:6 (1995), 980–986 (PMID: 7758169-indexed for MEDLINE).
245. Janssen-Heininger, Y.M., Poynter, M.E., Baeuerle, P.A., Free Radic. Biol. Med. 28:9 (2000), 1317–1327, 10.1016/S0891-5849(00)00218-5.
246. Moncada, S., Higgs, E.A., Nitric oxide and the vascular endothelium. Handb. Exp. Pharmacol.(176 Pt 1), 2006, 213–254 (PMID: 16999221 PubMed- indexed for MEDLINE).
247. Wilcox, J.N., Subramanian, R.R., Sundell, C.L., Tracey, W.R., Pollock, J.S., Harrison, D.G. et al., Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17:11 (1997), 2479–2488, 10.1161/01.ATV.17.11.2479.
248. Federici, M., Menghini, R., Mauriello, A., Hribal, M.L., Ferrelli, F., Lauro, D. et al., Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106:4 (2002), 466–472, 10.1161/01.CIR.0000023043.02648.51.
249. Siragusa, M., Fleming, I., The eNOS signalosome and its link to endothelial dysfunction. Pflugers Arch. 468:7 (2016), 1125–1137, 10.1007/s00424-016-1839-0.
250. Kennard, S., Ruan, L., Buffett, R.J., Fulton, D., Venema, R.C., TNFα reduces eNOS activity in endothelial cells through serine 116 phosphorylation and Pin1 binding: confirmation of a direct, inhibitory interaction of Pin1 with eNOS. Vasc. Pharmacol. 81 (2016), 61–68, 10.1016/j.vph.2016.04.003.
251. Kojda, G., Harrison, D., Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43:3 (1999), 562–571 (PMID: 10690328 PubMed- indexed for MEDLINE).
252. Widder, J.D., Fraccarollo, D., Galuppo, P., Hansen, J.M., Jones, D.P., Ertl, G., Bauersachs, J., Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 54:2 (2009), 338–344, 10.1161/HYPERTENSIONAHA.108.127928.
253. Vecchione, C., Carnevale, D., Di Pardo, A., Gentile, M.T., Damato, A., Cocozza, G. et al., Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 54:5 (2009), 1028–1034, 10.1161/HYPERTENSIONAHA.109.136572.
254. Dharmashankar, K., Widlansky, M.E., Vascular endothelial function and hypertension: insights and directions. Curr. Hypertens. Rep. 12:6 (2010), 448–455, 10.1007/s11906-010-0150-2.
255. Magen, E., Feldman, A., Cohen, Z., Alon, D.B., Linov, L., Mishal, J., Schlezinger, M., Potential link between C3a, C3b and endothelial progenitor cells in resistant hypertension. Am. J. Med. Sci. 339:5 (2010), 415–419, 10.1097/MAJ.0b013e3181d7d496.
256. Hage, F.G., Oparil, S., Xing, D., Chen, Y.F., McCrory, M.A., Szalai, A.J., C-reactive protein-mediated vascular injury requires complement. Arterioscler. Thromb. Vasc. Biol. 30:6 (2010), 1189–1195, 10.1161/ATVBAHA.110.205377.
257. Ghiadoni, L., Donald, A.E., Cropley, M., Mullen, M.J., Oakley, G., Taylor, M. et al., Mental stress induces transient endothelial dysfunction in humans. Circulation 102:20 (2000 Nov), 2473–2478, 10.1161/01.CIR.102.20.2473.
258. Black, P.H., Garbutt, L.D., Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 52:1 (2002), 1–23, 10.1016/S0022-3999(01)00302-6.
259. García-Bueno, B., Caso, J.R., Leza, J.C., Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci. Biobehav. Rev. 32:6 (2008), 1136–1151, 10.1016/j.neubiorev.2008.04.001.
260. Kuilman, T., Michaloglou, C., Mooi, W.J., Peeper, D.S., The essence of senescence. Genes Dev. 24:22 (2010), 2463–2479, 10.1101/gad.1971610.
261. Breitschopf, K., Zeiher, A.M., Dimmeler, S., Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 493:1 (2001), 21–25, 10.1016/S0014-5793(01)02272-4.
262. Pu, D.R., Liu, L., HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med. Hypotheses 70:2 (2008), 338–342, 10.1016/j.mehy.2007.05.025.
263. Kujoth, G.C., Hiona, A., Pugh, T.D., Someya, S., Panzer, K., Wohlgemuth, S.E. et al., Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:5733 (2005), 481–484, 10.1126/science.1112125.
264. Matsushita, H., Chang, E., Glassford, A.J., Cooke, J.P., Chiu, C.P., Tsao, P.S., eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ. Res. 89:9 (2001), 793–798, 10.1161/hh2101.098443.
265. Kurosu, H., Yamamoto, M., Clark, J.D., Pastor, J.V., Nandi, A., Gurnani, P. et al., Suppression of aging in mice by the hormone Klotho. Science 309:5742 (2005), 1829–1833, 10.1126/science.1112766.
266. Schächinger, V., Britten, M.B., Zeiher, A.M., Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:16 (2000), 1899–1906, 10.1161/01.CIR.101.16.1899.
267. Arrebola-Moreno, A.L., Laclaustra, M., Kaski, J.C., Noninvasive assessment of endothelial function in clinical practice. Rev. Esp. Cardiol. (Engl. Ed). 65:1 (2012), 80–90, 10.1016/j.recesp.2011.09.012.
268. Daiber, A., Steven, S., Weber, A., Shuvaev, V.V., Muzykantov, V.R., Laher, I. et al., Targeting vascular (endothelial) dysfunction. Br. J. Pharmacol., 2016, 10.1111/bph.13517.
269. Hirata, Y., Nagata, D., Suzuki, E., Nishimatsu, H., Suzuki, J., Nagai, R., Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int. Heart J. 51:1 (2010), 1–6, 10.1536/ihj.51.1.
270. Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S., Fadini, G.P., Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34:Suppl. 2 (2011), S285–S290, 10.2337/dc11-s239.
271. Xu, R.H., Liu, B., Wu, J.D., Yan, Y.Y., Wang, J.N., miR-143 is involved in endothelial cell dysfunction through suppression of glycolysis and correlated with atherosclerotic plaques formation. Eur. Rev. Med. Pharmacol. Sci. 20:19 (2016), 4063–4071 (PMID: 27775792 PubMed- indexed for MEDLINE).
272. Liu, G., Li, Y., Gao, X.G., microRNA-181a is upregulated in human atherosclerosis plaques and involves in the oxidative stress-induced endothelial cell dysfunction through direct targeting Bcl-2. Eur. Rev. Med. Pharmacol. Sci. 20:14 (2016), 3092–3100 (PMID: 27460740 PubMed- indexed for MEDLINE).
273. Li, P., Yin, Y.L., Guo, T., Sun, X.Y., Ma, H., Zhu, M.L. et al., Inhibition of aberrant microRNA-133a expression in endothelial cells by statin prevents endothelial dysfunction by targeting GTP cyclohydrolase 1 in vivo. Circulation, 2016, 10.1161/CIRCULATIONAHA.116.017949.
274. Loyer, X., Potteaux, S., Vion, A.C., Guérin, C.L., Boulkroun, S., Rautou, P.E. et al., Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ. Res. 114:3 (2014), 434–443, 10.1161/CIRCRESAHA.114.302213.
275. Daniel, J.M., Penzkofer, D., Teske, R., Dutzmann, J., Koch, A., Bielenberg, W., Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc. Res. 103:4 (2014), 564–572, 10.1093/cvr/cvu162.
276. Chen, W., Bacanamwo, M., Harrison, D.G., Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription. J. Biol. Chem. 283:24 (2008), 16293–16298, 10.1074/jbc.M801803200.
277. Zhang, Y., Qiu, J., Wang, X., Zhang, Y., Xia, M., AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler. Thromb. Vasc. Biol. 31:12 (2011), 2897–2908, 10.1161/ATVBAHA.111.237453.
278. Hyndman, K.A., Ho, D.H., Sega, M.F., Pollock, J.S., Histone deacetylase 1 reduces NO production in endothelial cells via lysine deacetylation of NO synthase 3. Am. J. Physiol. Heart Circ. Physiol. 307:5 (2014), H803–H809, 10.1152/ajpheart.00243.2014.
279. Pan, W., Yu, H., Huang, S., Zhu, P., Resveratrol protects against TNF-α-induced injury in human umbilical endothelial cells through promoting Sirtuin-1-induced repression of NF-KB and p38 MAPK. PLoS One, 11(1), 2016, e0147034, 10.1371/journal.pone.0147034.
280. Balestrieri, M.L., Rizzo, M.R., Barbieri, M., Paolisso, P., D'Onofrio, N., Giovane, A. et al., Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment. Diabetes 64:4 (2015), 1395–1406, 10.2337/db14-1149.
281. Zhang, Z.Q., Ren, S.C., Tan, Y., Li, Z.Z., Tang, X., Wang, T.T. et al., Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice. Sci Rep., 6, 2016, 23912, 10.1038/srep23912.
282. Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G. et al., Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:12 (2004), 1440–1446, 10.1001/jama.292.12.1440.
283. Rallidis, L.S., Lekakis, J., Kolomvotsou, A., Zampelas, A., Vamvakou, G., Efstathiou, S. et al., Close adherence to a Mediterranean diet improves endothelialfunction in subjects with abdominal obesity. Am. J. Clin. Nutr. 90:2 (2009), 263–268, 10.3945/ajcn.2008.27290.
284. Marin, C., Ramirez, R., Delgado-Lista, J., Yubero-Serrano, E.M., Perez-Martinez, P., Carracedo, J. et al., Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium. Am. J. Clin. Nutr. 93:2 (2011), 267–274, 10.3945/ajcn.110.006866.
285. Zamora-Ros, R., Serafini, M., Estruch, R., Lamuela-Raventós, R.M., Martínez-González, M.A., Salas-Salvadó J. et al., Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED study: evidence for a mechanism of antioxidant tuning. Nutr. Metab. Cardiovasc. Dis. 23:12 (2013), 1167–1174, 10.1016/j.numecd.2012.12.008.
286. Vilahur, G., Padró T., Casaní L., Mendieta, G., López, J.A., Streitenberger, S. et al., Polyphenol-enriched diet prevents coronary endothelial dysfunctionby activating the Akt/eNOS pathway. Rev. Esp. Cardiol. (Engl. Ed.) 68:3 (2015), 216–225, 10.1016/j.rec.2014.04.021.
287. Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M., Storelli, C., Martines, G. et al., Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelialcells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 527:2 (2012), 81–89, 10.1016/j.abb.2012.05.003.
288. Nascimento, N.R., Lessa, L.M., Kerntopf, M.R., Sousa, C.M., Alves, R.S., Queiroz, M.G. et al., Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proc. Natl. Acad. Sci. U. S. A. 103:1 (2006), 218–223, 10.1073/pnas.0509779103.
289. Hernández-Mijares, A., Bañuls, C., Rovira-Llopis, S., Álvarez, A., Orden, S., Rubio-Puchol, O. et al., Chronic consumption of an inositol-enriched beverage ameliorates endothelial dysfunction and oxidative stress in type 2 diabetes. J. Funct. Foods 18 (2015), 598–607, 10.1016/j.jff.2015.08.025.